Noncurative Resection Clinical Trial
— NoncurativeESDOfficial title:
Long-term Outcomes After Noncurative Endoscopic Resection of Colorectal Adenocarcinoma
Verified date | March 2021 |
Source | Istituto Clinico Humanitas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Patients with noncurative resection after ESD for CRC were considered for additional surgical treatment. Then, they either underwent surgery with curative intent or did not, according to patients choice and surgeons indication / contraindication. We performed a retrospective revision of outcome data by clinical report review or phone calls.
Status | Completed |
Enrollment | 500 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - undergoing non-curative colorectal endoscopic submucosal dissection (ESD). Exclusion Criteria: - Histology other than cancer (adenocarcinoma). - History of inflammatory bowel disease (IBD). - Genetic conditions predisposing to CR. - Lost to follow up or less than 6 months of follow up. |
Country | Name | City | State |
---|---|---|---|
Italy | Endoscopy Unit, Humanitas Research Hospital | Rozzano | Milano |
Lead Sponsor | Collaborator |
---|---|
Istituto Clinico Humanitas |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Survival | Overall survival cancer-specific survival and disease-free survival rate after noncurative ESD. | 6 Months |